Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D005123:Eye / Q000187:drug effects; D005260:Female; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D008099:Liver / Q000187:drug effects; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D010640:Phenothiazines / Q000008:administration & dosage* / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D014556:Urine
D010640:Phenothiazines; D014149:Tranquilizing Agents